Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
GW Pharmaceuticals has revealed positive results from a clinical study of Sativex in the treatment of cancer pain.
It said the authors of a paper published in the 'Journal of Pain and Symptom Management' conclude that "this study shows that Sativex is efficacious for relief of pain in patients with advanced cancer pain not fully relieved by strong opioids".
Preliminary results from this study have previously been announced by GW.
Story provided by Business Financial Newswire
Shares in British banks rose on the FTSE 100 in morning trading following positive news on the Greek debt crisis.
Unite, the union, has gone to international unions, in its attempts to bring the...
© 2010 The IBTimes Company Ltd. All Rights Reserved.
Partners 
EMAIL
PRINT
RSS
SHARE
